Lidocaine attenuates the hypotensive and inflammatory responses to endotoxemia in rabbits
- 1 April 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 24 (4) , 642-646
- https://doi.org/10.1097/00003246-199604000-00016
Abstract
To assess the effects of lidocaine on the hemodynamic and inflammatory responses to Escherichia coli endotoxemia in rabbits. Prospective, randomized, controlled experimental study. University laboratory. Twenty-seven female Japanese rabbits, anesthetized with urethane and ventilated mechanically. Animals were randomly assigned to one of three groups: a) endotoxemic control group (n = 9), receiving intravenous Escherichia coli endotoxin (0.5 mg/kg bolus) via the mesenteric vein; b) laparotomy control group (n = 9), treated identically to the endotoxemic control group, except for substitution of 0.9% saline for endotoxin; and c) lidocaine-treated group (n = 9), treated identically to the endotoxemic controls and additionally, intravenous lidocaine (3 mg/kg bolus, followed by infusion at 2 mg/kg/hr) was administered immediately after endotoxin We compared hemodynamics, blood gases, and microscopic findings of lung tissue obtained at necropsy in each group. Laparotomy alone had a minimal effect on the parameters and findings. Endotoxin injection decreased mean systolic arterial pressure from 135 +/- 6 (SD) to 95 +/- 25 mm Hg (p < .05) and increased the mean base deficit from -1.2 +/- 1.8 to -14.4 +/- 4.2 mmol/L (p < .05), and caused the infiltration of neutrophils into the lungs. Lidocaine administration abolished the hypotension and attenuated the increase the base deficit to -9.5 +/- 2.1 mmol/L (p < .05) and the cellular infiltration in comparison with endotoxemic controls. Lidocaine attenuated the hemodynamic and inflammatory responses to endotoxemia in rabbits. Findings suggest that lidocaine administration may prevent the development of hypotension and metabolic acidosis during endotoxemia.Keywords
This publication has 24 references indexed in Scilit:
- Inhibitory effects of amide local anaesthetics on stimulus‐induced human leukocyte metabolic activation, LTB4release and IL‐1 secretionin vitroActa Anaesthesiologica Scandinavica, 1993
- American College of Chest Physicians/Society of Critical Care Medicine Consensus ConferenceCritical Care Medicine, 1992
- Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia. Comparison to Escherichia coli.Journal of Clinical Investigation, 1991
- Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock.The Journal of Experimental Medicine, 1989
- Tumor Necrosis Factor and Interleuktn-1 in the Serum of Children with Severe Infectious PurpuraNew England Journal of Medicine, 1988
- Shock and Tissue Injury Induced by Recombinant Human CachectinScience, 1986
- Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolites.Journal of Clinical Investigation, 1982
- Inflammation and MediatorsInternational Journal of Dermatology, 1980
- Lidocaine inhibits granulocyte adherence and prevents granulocyte delivery to inflammatory sitesBlood, 1980
- Influence of local anesthetics upon human polymorphonuclear leukocyte function in vitro. Reduction of lysosomal enzyme release and superoxide anion production.The Journal of Experimental Medicine, 1977